Ascendis Pharma
ASND
ASND
241 hedge funds and large institutions have $10.1B invested in Ascendis Pharma in 2025 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 76 increasing their positions, 87 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 14 → 14 (0)
13% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 87
38% less call options, than puts
Call options by funds: $23.8M | Put options by funds: $38.3M
Holders
241
Holding in Top 10
14
Calls
$23.8M
Puts
$38.3M
Top Buyers
| 1 | +$168M | |
| 2 | +$51.2M | |
| 3 | +$51M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$44.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$35.7M |
Top Sellers
| 1 | -$70.1M | |
| 2 | -$57.6M | |
| 3 | -$41.6M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$30.2M |
| 5 |
BlackRock
New York
|
-$21.2M |
